{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:12:36Z","timestamp":1792894356616,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T00:00:00Z","timestamp":1419811200000},"content-version":"vor","delay-in-days":6147,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[1998,3]]},"DOI":"10.1111\/j.1469-0691.1998.tb00683.x","type":"journal-article","created":{"date-parts":[[2008,10,27]],"date-time":"2008-10-27T07:20:53Z","timestamp":1225092053000},"page":"S9-S14","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S1","title":["Grepafloxacin: microbiological properties"],"prefix":"10.1016","volume":"4","author":[{"given":"Michael S.","family":"Marriott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.1998.tb00683.x_bib1","series-title":"Posters presented at 31st Interscience Conference on Antimicrobial Agents and Chemotherapy","article-title":"In vitro and in vivo activities of OPC-17116, a novel fluoroquinolone [poster 1472]","author":"Nishino","year":"1991"},{"key":"10.1111\/j.1469-0691.1998.tb00683.x_bib2","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/AAC.36.10.2185","article-title":"Comparative in vitro activities of a new quinolone, OPC-17116, possessing potent activity against Gram-positive bacteria","volume":"36","author":"Wakebe","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.1998.tb00683.x_bib3","first-page":"74","article-title":"In vitro and in vivo antibacterial activity of grepafloxacin","volume":"43","author":"Ohguro","year":"1995","journal-title":"Jpn J Chemother"},{"key":"10.1111\/j.1469-0691.1998.tb00683.x_bib4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1128\/AAC.41.2.471","article-title":"Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones","volume":"41","author":"Pan","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1111\/j.1469-0691.1998.tb00683.x_bib5","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1128\/AAC.38.9.2095","article-title":"Dissociated resistance among fluoroquinolones","volume":"38","author":"Thomson","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.1998.tb00683.x_bib6","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/BF02447932","article-title":"Activity of grepafloxacin against respiratory isolates of Streptococcus pneumoniae","volume":"16","author":"Johnson","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.1998.tb00683.x_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0732-8893(96)00161-7","article-title":"Tentative interpretive criteria for testing the susceptibility of Streptococcus pneumoniae to eight fluoroquinolones","volume":"26","author":"Fuchs","year":"1996","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.1998.tb00683.x_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jac\/40.suppl_1.27","article-title":"The activity of grepafloxacin against respiratory pathogens in the UK","volume":"40","author":"Wise","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.1998.tb00683.x_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/1120009X.1993.11739245","article-title":"In vitro comparison of OPC-17116, a new fluoroquinolone, against more than 5,000 recent clinical isolates from five medical centers","volume":"5","author":"Sader","year":"1993","journal-title":"J Chemother"},{"issue":"3","key":"10.1111\/j.1469-0691.1998.tb00683.x_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0732-8893(95)00021-2","article-title":"Tentative criteria for determining the in vitro susceptibilities of Haemophilus influenzae, including quality control parameters, to two fluoroquinolones (grepafloxacin and PD 131628)","volume":"21","author":"Sewell","year":"1995","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.1998.tb00683.x_bib11","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1128\/AAC.37.8.1726","article-title":"Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to a new quinolone, OPC-17116","volume":"37","author":"Kenny","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.1998.tb00683.x_bib12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1128\/AAC.37.4.801","article-title":"In vitro and in vivo antichlamydial activities of newly developed quinolone antimicrobial agents","volume":"37","author":"Kimura","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.1998.tb00683.x_bib13","author":"Dubois","year":"1997","journal-title":"In vitro susceptiblity study of grepafloxacin and five other antibiotics against Legionella species (abstract)"},{"key":"10.1111\/j.1469-0691.1998.tb00683.x_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jac\/31.4.497","article-title":"The in vitro activity of OPC-17116, a new 5-methyl substituted quinolone","volume":"31","author":"Wise","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.1998.tb00683.x_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/40.suppl_1.31","article-title":"The in vitro activity of grepafloxacin against Chlamydia spp., Mycoplasma spp, Ureaplasma urealyticum and Legionella spp","volume":"40","author":"Ridgway","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.1998.tb00683.x_bib16","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1128\/AAC.38.10.2471","article-title":"Activity of CP99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin and piperacillin-tazobactam against 489 anaerobes","volume":"38","author":"Spangler","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.1998.tb00683.x_bib17","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/BF01962081","article-title":"In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones","volume":"11","author":"Sader","year":"1992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.1998.tb00683.x_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/clinids\/15.1.77","article-title":"Antimicrobial resistance in Streptococcus pneumoniae: an overview","volume":"15","author":"Appelbaum","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.1998.tb00683.x_bib19","first-page":"412","author":"Focht","year":"1997","journal-title":"In vitro activity of grepafloxacin compared with other antimicrobial agents against bacterial strains from upper and lower RTIs (abstract)"},{"key":"10.1111\/j.1469-0691.1998.tb00683.x_bib20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1128\/AAC.36.3.573","article-title":"In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116","volume":"36","author":"Imada","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.1998.tb00683.x_bib21","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/jac\/32.6.916","article-title":"Postantibiotic effects of E-4868 and OPC-17116","volume":"32","author":"Sanford","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.1998.tb00683.x_bib22","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1128\/AAC.38.10.2340","article-title":"Evaluation of OPC-17116 against important pathogens that cause respiratory tract infections","volume":"38","author":"Wakebe","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.1998.tb00683.x_bib23","article-title":"OPC-17116; a novel broad-spectrum 5-methyl quinolone derivative: therapeutic effects against various infections in animals (abstract 1475)","author":"Ohmori","year":"1991","journal-title":"31st Interscience Conference on Antimicrobial Agents and Chemotherapy"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.1998.tb00683.x_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-199700331-00003","article-title":"Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males","volume":"33","author":"Efthymiopoulos","year":"1997","journal-title":"Clin Pharmacokinet"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14650242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14650242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T18:55:46Z","timestamp":1557860146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14650242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":24,"alternative-id":["S1198743X14650242"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.1998.tb00683.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}